My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Moderna, Inc. - Common Stock (NQ:MRNA)

49.88 +0.18 (+0.36%)

Streaming Delayed Price Updated: 10:04 AM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Moderna, Inc. - Common Stock

< Previous 1 2

...

26 27 28 29 30 31 32 33 34

...

99 100 Next >

Magnificent 7 Miss Out, 2 Cybersecurity Stocks Stand Firm, Retailers Lag In Volatile August: Here Are The Top S&P 500 Gainers And Losers ↗

August 31, 2024

The equity market was volatile in August, with the weakness seen early in the month dissipating amid a rise in rate-cut bets.

Via Benzinga

Topics Stocks

Wellness In Your Personal Life Unleashes Productivity At Work ↗

August 30, 2024

Our world is obsessed with individual productivity.

Via Investor's Business Daily

Moderna And BioNTech Bet On Personalized Cancer Vaccines To Revive Fortunes After Dwindling COVID-19 Vaccine Sales ↗

August 29, 2024

BioNTech and Moderna are advancing personalized cancer vaccines using mRNA technology. Despite promising early results, these innovative treatments face challenges in cost, scalability, and...

Via Benzinga

This Moderna Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday ↗

August 28, 2024

Via Benzinga

Moderna Unusual Options Activity ↗

August 27, 2024

Via Benzinga

$100 Invested In This Stock 5 Years Ago Would Be Worth $500 Today ↗

August 23, 2024

Via Benzinga

Moderna's Options: A Look at What the Big Money is Thinking ↗

August 21, 2024

Via Benzinga

Chinese E-Commerce Giant Drops 35% In 2 Days, But Analysts See 92% Upside Potential ↗

August 27, 2024

PDD Holdings Inc. (NASDAQ: PDD) saw a 29% drop after disappointing Q2 results, but analysts remain bullish with price targets ranging from $84 to $185.

Via Benzinga

Americans To Access COVID-19 Test Kits For Free As US Government Restarts Free At-Home Program ↗

August 26, 2024

US households can order free COVID-19 tests starting in late September as the government reopens the program ahead of the fall virus season.

Via Benzinga

Snowflake, JD.com And Temu Parent PDD Are Among Top 8 Large Cap Losers Last Week (Aug 18-Aug 24): Are The Others In Your Portfolio? ↗

August 25, 2024

8 large-cap stocks were the worst performers last week: TBN, GFI, SNOW, NTES, BEN, JD, PDD, MRNA. Are they in your portfolio?

Via Benzinga

The Stock Market Isn't Rocking This Month But The S&P 500 Is Headed For Its Best August In 3 Years ↗

August 23, 2024

Kellanova and Fortinet are leading the S&P 500's August performance.

Via Investor's Business Daily

Topics Stocks

Demystifying Moderna: Insights From 11 Analyst Reviews ↗

August 15, 2024

Via Benzinga

Smart Money Is Betting Big In MRNA Options ↗

August 13, 2024

Via Benzinga

Market Whales and Their Recent Bets on MRNA Options ↗

August 12, 2024

Via Benzinga

Europe Approves Moderna's RSV Vaccine For Adults 60 And Over ↗

August 23, 2024

Moderna secures European Commission approval for its mRNA RSV vaccine, mRESVIA, to protect adults 60+ from RSV-related respiratory disease. The approval follows positive EMA CHMP opinion, based on...

Via Benzinga

Nasdaq 100 Slumps 1.6% As Traders Turn Cautious Ahead Of Powell's Jackson Hole Address ↗

August 22, 2024

The Nasdaq 100 fell 1.6% on Thursday as investors awaited Fed Chair Powell's Jackson Hole speech. Private sector data and tech stock declines added to bearish sentiment.

Via Benzinga

Topics Economy

FDA Approves Updated COVID Vaccines From Pfizer And Moderna, But Leaves Out Novavax's Shot ↗

August 22, 2024

The FDA granted emergency use authorization for updated mRNA COVID-19 vaccines targeting the Omicron KP.2 strain, including new formulas from Moderna and Pfizer/BioNTech. These vaccines, designed to...

Via Benzinga

Stocks Move Lower As Rate Cut Enthusiasm Fades ↗

August 22, 2024

The enthusiasm that followed the release of the Federal Reserve's meeting minutes is already fading.

Via Talk Markets

Topics Economy

S&P 500, Nasdaq 100 Snap 8-Day Winning Streak: What Triggered Wall Street's Setback On Tuesday? ↗

August 20, 2024

S&P 500 ended Tuesday's session with slight declines, halting its best winning streak since May 2024. Here's the latest.

Via Benzinga

Topics Stocks

S&P 500, Nasdaq 100 Extend 8-Session Winning Streak As Wall Street Jitters 'Go Poof': Monday's Key Stock Movers ↗

August 19, 2024

Via Benzinga

Topics Stocks

Novavax Stock Rocketed This Year, But Challenges Persist. Is It A Buy Or A Sell? ↗

August 19, 2024

Its 12-month relative strength performance is impressive, but Novavax now faces resistance.

Via Investor's Business Daily

FDA Set To Approve COVID-19 Vaccines As Soon As This Week: Stocks, ETFs To Watch ↗

August 19, 2024

The FDA may approve updated COVID-19 vaccines this week to combat recent strains as the country endures a significant summer outbreak.

Via Benzinga

Topics ETFs

Pfizer and BioNTech's Combo Shot Missed the Mark. Is It Time to Sell? ↗

August 19, 2024

A clinical-trial failure for Pfizer and BioNTech means Moderna is leading the race to develop a combo shot for the flu and COVID-19.

Via The Motley Fool

Pfizer, BioNTech's COVID-19/Flu Combo Vaccine Fails To Meet Key Goal In Late-Stage Study ↗

August 16, 2024

Pfizer and BioNTech report Phase 3 results for their combined mRNA vaccine against influenza and COVID-19. The trial met one of two primary immunogenicity objectives. Adjustments are planned to improve...

Via Benzinga

Struggling COVID-19 Vaccines From AstraZeneca, BioNTech/Pfizer, Moderna Cut Incidence Of Arterial Thromboses That Cause Heart Attacks, Strokes, British Study Shows ↗

August 13, 2024

COVID-19 vaccinations could lower the incidence of heart attacks and strokes, according to a new study by UK universities. The research shows a significant reduction in cardiovascular events among...

Via Benzinga

Long Covid Remains Diagnostic Mystery, Diagnosis Remains Elusive; National Institutes of Health-Funded Study Shows ↗

August 13, 2024

A recent NIH study reveals no clear diagnostic test for Long Covid, highlighting ongoing challenges in identifying and treating the condition affecting millions of Americans. Researchers continue to...

Via Benzinga

3 Biotech Stocks Poised for a Comeback After Last Week’s Market Meltdown ↗

August 13, 2024

Investors should closely watch these three biotech stocks as their strong prospects are likely to help the rebound from market volatility.

Via InvestorPlace

10 Health Care Stocks With Whale Alerts In Today's Session ↗

August 12, 2024

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

August 08, 2024

Via Benzinga

Expanding the Cloud for AI ↗

August 08, 2024

Amazon, Alphabet, Microsoft, and Meta are all spending a ton of money to build out cloud capabilities to fuel the next phase of AI growth. But the market isn't sold on that spend yet.

Via The Motley Fool

Topics Artificial Intelligence

< Previous 1 2

...

26 27 28 29 30 31 32 33 34

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.